89bio, Inc. ( ETNB) - Key Metrics
Stock symbol ETNB is outdated, potentially delisted? Maybe it is available on other exchange?
ETNB Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2024Q3 | ? | -$1.49 | -$1.46 | -$1.46 |
| 2024Q2 | ? | -$0.48 | -$0.61 | -$0.61 |
| 2024Q1 | ? | -$0.54 | -$0.41 | -$0.41 |
| 2023Q4 | $0 | -$0.50 | -$0.42 | -$0.43 |
| 2023Q3 | ? | -$0.45 | -$0.40 | -$0.40 |
ETNB Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2024Q3 | ? | -1.24 |
| 2024Q2 | ? | -4.04 |
| 2024Q1 | ? | -4.97 |
| 2023Q4 | 0.00% | -5.60 |
| 2023Q3 | ? | -8.49 |
ETNB Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2024Q3 | -19.68% | ? |
| 2024Q2 | -7.90% | ? |
| 2024Q1 | -3.86% | ? |
| 2023Q4 | -3.80% | 0.00% |
| 2023Q3 | -2.58% | ? |
ETNB
Price: $14.84
52 week price:
Payout Ratio Range:
Earnings Per Share: -3.69 USD
P/E Ratio: -4.02
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.6 million
Market Capitalization: 2.2 billion